Another report[22] found that patients with cervical cancer who expressed higher levels of VEGFR2 were associated with better clinical responses (P = 0.02) using a 0.54 cut-off value from receiver operating characteristic curve analysis. This evidence concerns the gene KDR and cervical cancer.